SOX10 and central nervous system cancer: These clues, combined with reports that SOX10 is highly expressed in gliomas [22, 23] and that reduced miR‐637 expression is an unfavorable prognostic marker for gliomas [19], encouraged us to examine whether miR‐637 might act through SOX10 to regulate stemness of gliomas.